Lam Research (NASDAQ:LRCX - Get Free Report) had its price objective raised by analysts at Wells Fargo & Company from $135.00 to $145.00 in a research note issued on Thursday,Benzinga reports. The brokerage currently has an "equal weight" rating on the semiconductor company's stock. Wells Fargo & Company's price target points to a potential upside of 0.38% from the stock's current price.
Several other research analysts have also recently issued reports on LRCX. Cowen reiterated a "buy" rating on shares of Lam Research in a report on Thursday. Erste Group Bank started coverage on shares of Lam Research in a research report on Thursday, August 14th. They set a "buy" rating for the company. HSBC set a $127.00 price target on shares of Lam Research and gave the company a "hold" rating in a research report on Tuesday, September 30th. Barclays set a $142.00 price target on shares of Lam Research and gave the company an "equal weight" rating in a research report on Monday. Finally, Deutsche Bank Aktiengesellschaft raised shares of Lam Research from a "hold" rating to a "buy" rating and increased their price objective for the company from $100.00 to $150.00 in a research report on Monday, September 29th. One investment analyst has rated the stock with a Strong Buy rating, twenty-five have assigned a Buy rating and eight have given a Hold rating to the company. According to MarketBeat, Lam Research presently has an average rating of "Moderate Buy" and an average price target of $144.08.
Get Our Latest Stock Report on LRCX
Lam Research Trading Up 2.3%
Shares of LRCX traded up $3.20 during midday trading on Thursday, hitting $144.45. The stock had a trading volume of 2,179,439 shares, compared to its average volume of 11,878,382. Lam Research has a 1 year low of $56.32 and a 1 year high of $153.70. The firm has a market cap of $182.16 billion, a PE ratio of 34.72, a price-to-earnings-growth ratio of 1.76 and a beta of 1.84. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.21 and a quick ratio of 1.55. The stock's 50 day moving average is $121.38 and its 200 day moving average is $98.38.
Lam Research (NASDAQ:LRCX - Get Free Report) last posted its quarterly earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 EPS for the quarter, topping analysts' consensus estimates of $1.22 by $0.04. The firm had revenue of $5.32 billion for the quarter, compared to analysts' expectations of $5.23 billion. Lam Research had a net margin of 29.07% and a return on equity of 58.17%. The business's revenue for the quarter was up 27.7% on a year-over-year basis. During the same period in the prior year, the business posted $0.86 earnings per share. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. As a group, analysts forecast that Lam Research will post 3.71 EPS for the current fiscal year.
Insider Transactions at Lam Research
In related news, SVP Vahid Vahedi sold 52,190 shares of the business's stock in a transaction dated Monday, October 13th. The shares were sold at an average price of $138.90, for a total value of $7,249,191.00. Following the sale, the senior vice president directly owned 251,047 shares in the company, valued at approximately $34,870,428.30. The trade was a 17.21% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.31% of the company's stock.
Hedge Funds Weigh In On Lam Research
Institutional investors have recently bought and sold shares of the company. Smallwood Wealth Investment Management LLC acquired a new position in Lam Research in the 1st quarter valued at about $26,000. IMG Wealth Management Inc. acquired a new stake in shares of Lam Research in the second quarter valued at approximately $26,000. Howard Hughes Medical Institute acquired a new stake in shares of Lam Research in the second quarter valued at approximately $27,000. Strategic Wealth Investment Group LLC acquired a new stake in shares of Lam Research in the second quarter valued at approximately $29,000. Finally, Delos Wealth Advisors LLC purchased a new position in Lam Research in the second quarter worth $30,000. 84.61% of the stock is owned by institutional investors and hedge funds.
Lam Research Company Profile
(
Get Free Report)
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Lam Research, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.
While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.